who prescribes glp 1 What to Make of the GLP-1 Coverage and Cost Landscape Who Can Prescribe GLP-1 for

Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1-7 randomised controlled trials

helping patients feel fuller for longer

Wegovy (higher-dose semaglutide, FDA-approved specifically for chronic weight management) faces the same coverage limitations as Ozempic when prescribed for weight loss

Hydration is equally important and often harder to manage on trail when youre focused on distance and terrain

Liraglutide reduced this renal outcome by 22% after 3.8 years follow up, whereas semaglutide showed a reduction of 36% after 2.1 years

Restraints High Cost and Potential Gastrointestinal Side Effects May Restrain Market Growth The relatively high cost of GLP-1 receptor agonists can be a significant restraint on market growth, particularly in regions with limited healthcare access or reimbursement